Vimarsana
Biggest News Aggregation in the World

Page 6 - Wave Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wave Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wave Life Sciences Today - Breaking & Trending Today

Newtyn Management LLC Purchases 10,000 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Vimarsana News

Newtyn Management LLC Purchases 10,000 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)

Newtyn Management LLC increased its stake in Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 2.0% during the 3rd quarter, Holdings Channel reports. The firm owned 510,000 shares of the company’s stock after purchasing an additional 10,000 shares during the quarter. Wave Life Sciences comprises approximately 0.7% of Newtyn Management LLC’s portfolio, making the […]

Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy - Vimarsana News

Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy

Presentations include data for WVE-N531 that provide first clinical evidence of a potential therapeutic for DMD accessing satellite cells, which are important for potential muscle regeneration ...

Wave Life Sciences Ltd. (NASDAQ:WVE) Receives $8.40 Consensus Price Target from Analysts - Vimarsana News

Wave Life Sciences Ltd. (NASDAQ:WVE) Receives $8.40 Consensus Price Target from Analysts

Wave Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) has received an average recommendation of “Moderate Buy” from the six research firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12-month target […]

Sarepta data show new Duchenne drug's potency, but highlight side effects - Vimarsana News

Sarepta data show new Duchenne drug's potency, but highlight side effects

BioPharma

James J. Burns & Company LLC Has $190,000 Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - Vimarsana News

James J. Burns & Company LLC Has $190,000 Stake in Wave Life Sciences Ltd. (NASDAQ:WVE)

James J. Burns & Company LLC boosted its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Free Report) by 10.2% in the 3rd quarter, Holdings Channel.com reports. The firm owned 33,049 shares of the company’s stock after purchasing an additional 3,049 shares during the quarter. James J. Burns & Company LLC’s holdings in […]

Source: wkrb13.com